SQ-109

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSQ-109
Drug Alias NameSQ-109NSC-722041
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsHelicobacter pylori infectionTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTanzaniaSouth Africa
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSequella Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSequella IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infectionTuberculosis, PulmonaryTuberculosis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank